nigericin has been researched along with sennoside a&b in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, W; Lan, Y; Li, S; Meng, X; Shi, X; Wang, F; Wang, H; Wu, J; Zhang, J | 1 |
1 other study(ies) available for nigericin and sennoside a&b
| Article | Year |
|---|---|
Sennoside A is a novel inhibitor targeting caspase-1.
Topics: Adenosine Triphosphate; Carrageenan; Caspase 1; Caspases; Inflammasomes; Interleukin-18; Interleukin-1beta; Lipopolysaccharides; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Peptide Hydrolases; Reactive Oxygen Species; RNA, Small Interfering; Sennosides | 2022 |